Sanctuary Advisors LLC Buys Shares of 40,058 Cigna Group $CI

Sanctuary Advisors LLC purchased a new stake in shares of Cigna Group (NYSE:CI) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 40,058 shares of the health services provider’s stock, valued at approximately $11,043,000.

A number of other hedge funds have also modified their holdings of the stock. Wilkerson Advisory Group LLC purchased a new stake in shares of Cigna Group during the fourth quarter worth $25,000. Cedar Mountain Advisors LLC grew its stake in Cigna Group by 161.9% in the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 68 shares in the last quarter. Johnson Financial Group Inc. purchased a new position in Cigna Group in the second quarter valued at about $29,000. Kemnay Advisory Services Inc. acquired a new position in Cigna Group in the 4th quarter worth about $29,000. Finally, Prosperity Bancshares Inc acquired a new position in Cigna Group in the 4th quarter worth about $29,000. 86.99% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Cigna Group

In related news, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the sale, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This represents a 27.52% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Nicole S. Jones sold 2,677 shares of the firm’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total transaction of $748,515.97. Following the completion of the transaction, the insider owned 25,880 shares in the company, valued at $7,236,306.80. The trade was a 9.37% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 23,012 shares of company stock valued at $6,386,550. 0.60% of the stock is owned by insiders.

Cigna Group Stock Performance

Shares of NYSE CI opened at $280.32 on Tuesday. The business’s 50-day simple moving average is $283.92 and its 200-day simple moving average is $281.48. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. Cigna Group has a 52 week low of $239.51 and a 52 week high of $315.47. The firm has a market cap of $74.07 billion, a price-to-earnings ratio of 11.60, a P/E/G ratio of 0.95 and a beta of 0.29.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.18. The firm had revenue of $70.04 billion during the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The company’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same period in the previous year, the company earned $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, equities research analysts expect that Cigna Group will post 30.51 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be paid a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date is Tuesday, September 8th. Cigna Group’s payout ratio is presently 25.82%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on CI shares. Raymond James Financial lowered Cigna Group from a “strong-buy” rating to an “outperform” rating and reduced their price target for the company from $350.00 to $320.00 in a report on Monday, August 3rd. Wells Fargo & Company increased their price objective on Cigna Group from $305.00 to $307.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Deutsche Bank Aktiengesellschaft lowered shares of Cigna Group from a “buy” rating to a “hold” rating and cut their price objective for the company from $303.00 to $302.00 in a research report on Wednesday, May 20th. Jefferies Financial Group cut shares of Cigna Group from a “buy” rating to a “hold” rating and reduced their target price for the company from $336.00 to $307.00 in a research note on Tuesday, August 4th. Finally, Morgan Stanley boosted their target price on shares of Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 20th. Fifteen equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat.com, Cigna Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $339.45.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.